Transparency Market Research presents this most up-to-date research on “Equine Healthcare Market (Diagnostic Product Type – Equine Pregnancy and Gestation Diagnostic Products and Equine Genotyping Analysis Products; Therapeutic Product Type – Equine Vaccines Market, Equine Antibacterials Market, Equine Antivirals Market, Equine Antiprotozoals Market, Equine Dopamine Agonists Market, Equine Anti-inflammatory Drugs Market, and Equine Laxatives Market; Equine Supplement Products Type – Equine Performance Supplements and Equine Protection Products) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 – 2019”
The global equestrian market is a multi-billion dollar industry that comprises horse racing and betting, leisure and competitive riding and has spawned and supports multifarious secondary markets; the equine healthcare market ranks as the one of the key secondary markets. This report exclusively studies the market for equine healthcare from varied aspects such as, in terms of equine diagnostic products, equine therapeutic products and equine supplement products; and is thus classified into three prime segments namelyequine diagnostic products market, equine therapeutic products market and equine supplement products market. The market size and forecast for the period 2013–2019, in terms of USD million, considering 2012 as the base year has been provided for each segment and sub-segments in the report. The compound annual growth rate (CAGR) for each segment and sub-segments has been provided for the forecast period from 2013–2019.
Geographically, the equine healthcare market has been classified into four regions -North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region along with their market growth rate has been highlighted. The market overview section of the report comprises of a qualitative analysis of the market in terms of drivers, restraintsand opportunities, along with market attractiveness analysis.
The report concludes with the competitive landscape and company profiles of few market players in this industry, as of 2012. The market players profiled in this report include Elanco Animal Health, Merck Animal Health, Zoetis (Pfizer Animal Health), Boehringer Ingelheim Vetmedica, Bayer Animal Health, Equine Health U.K., Equine Orthotics and Prosthetics, Affymetrix, Equine Diagnostics, Signostics and Purina.
Browse Global Strategic Business Report:
Genotype Analyzers to Exhibit Positive Signs and Grow Significantly
Genotype analyzers or breed quality analyzers are an important part of the equine diagnostics product segment in the global equine healthcare market. This particular segment is likely to expand at a 15% CAGR during the forecast period. This growth can be attributed to the rising sales of analysis kits across the globe. The market is segmented into therapeutic, supplement, and diagnostic products. Equine diagnostic products is expected to lead the market in the near future.
North America Market to be Adversely Effected as Horse Owners Close down Business
Going till 2019, almost 50% of the horse-owners in North American showed deteriorating interests in joining the equine events, shows, and racing. The horse-owners further stated that they are expected to limit equestrian operations only till the ‘breeding’ sub-set of the value-chain to capitalize on the return on investments and also export high quality breed of horses to specific destinations such as China. Thus, the North America equine healthcare market is likely to decay by -1.0% until 2019.
The companies in the market are Equine Orthotics and Prosthetics, Equine Health U.K., Zoetis (Pfizer Animal Health), Elanco Animal Heath, Affymetrix, Boehringer Ingelheim Vetmedica, and Merck Animal Health.
Download Exclusive Brochure of This Report :
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453